Design and development of gliclazide-loaded chitosan for oral sustained drug delivery: In vitro/in vivo evaluation

Journal of Microencapsulation

Volumn 28, Issue 2, 2011, Pages 122-133

  Barakat, Nahla S ^a   Almurshedi, Alanood S ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Chitosan; gliclazide; microparticles; pectin; sustained release

Indexed keywords

CHITOSAN; CROSS LINKING REAGENT; GLICLAZIDE; GLUTARALDEHYDE; PECTIN; POLYELECTROLYTE; TRIPOLYPHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; MALE; MEMBRANE MICROPARTICLE; NONHUMAN; PARTICLE SIZE; PH; RABBIT; SCANNING ELECTRON MICROSCOPY; SOLUTION AND SOLUBILITY; STREPTOZOCIN DIABETES; SUSTAINED DRUG RELEASE;

ADMINISTRATION, ORAL; ANIMALS; CHITOSAN; DIABETES MELLITUS, EXPERIMENTAL; DRUG DELIVERY SYSTEMS; GLICLAZIDE; GLUTARAL; HYDROGEN-ION CONCENTRATION; HYPOGLYCEMIC AGENTS; MALE; PARTICLE SIZE; RATS;

EID: 79251612354     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2010.535621     Document Type: Article

References (45)

1. Allen T, 1975. Particle size measurements. 2nd ed. London: Chapman & Hall, p 74.
2. Alsarra IA, Neau SH, Howard MA. Effects of preparative parameters on the properties of chitosan hydrogel beads containing Candida rugosa lipase. Biomaterials, 2004;25:2645-55.
3. Alves NM, Mano JF. Chitosan derivatives obtained by chemical modifications for biomedical and environmental applications. Int J Biol Macromol, 2008;43:401-14.
4. Anal AK, Bhopatkar D, Tokura S, Tamura H, Stevens WF. Chitosan-alginate multilayer microparticles for gastric passage and controlled intestinal release of protein. Drug Dev Ind Pharm, 2003;29:713-24.
5. Aral C, Akbuǧa J. Alternative approach to the preparation of chitosan beads. Int J Pharm, 1998;168:9-15.
6. Barat R, Srinatha A, Pandit JK, Anupurba S, Mittal N. Chitosan inserts for periodontitis: Influence of drug loading plasticizer and crosslinking on in vitro metronidazole release. Acta Pharm, 2007;57:469-77.
7. Bernkop-Schnürch A. Chitosan and its derivatives: Potential excipients for peroral peptide delivery systems. Int J Pharm, 2000;194:1-13.
8. Campbell DB, Lavielle R, Nathan C. The mode of action and clinical pharmacology of gliclazide: A review. Diabetes Res Clin Pract, 1991;14: S21-36.
9. Chen S, Liu M, Jin S, Wang B. Preparation of ionic-crosslinked chitosanbased gel beads and effect of reaction conditions on drug release behaviors. Int J Pharm, 2008;349:180-7.
10. Desai SJ, Simonelli AP, Higuchi WI. Investigation of factors influencing release of solid drug dispersed in inert matrices. J Pharm Sci, 1965;54:1459-64.
11. Ferrari F, Rossi S, Martini A, Muggetti L, De Ponti R, Caramella C. Technological induction of mucoadhesive properties on waxy starches by grinding. Eur J Pharm Sci, 1997;5:277-85.
12. González-Rodrǐguez ML, Holgado MA, Sánchez-Lafuente C, Rabasco AM, Fini A. Alginate/chitosan particulate systems for sodium diclofenac release. Int J Pharm, 2002;232:225-234.
13. Grover JK, Rathi SS, Vats V. Amelioration of experimental diabetic neuropathy and gastropathy in rats following oral administration of plant (Eugenia jambolana, Mucurna pruriens and Tinospora cordifolia) extracts. Indian J Exper Biol, 2002;3:273-76.
14. Gupta KC, Ravi Kumar MNV. Drug release behavior of microparticles and microgranules of chitosan. Biomaterials, 2000;21:1115-19.
15. Ishak RA, Awad GA, Mortada ND, Nour SAK. Preparation, in vitro and in vivo evaluation of stomach-specific metronidazole-loaded alginate beads as local anti-helicobacter Pylori therapy. J Contr Rel, 2007;119:207-14.
16. Li J, Chatterjee K, Medek A, Shalaev E, Zografi G. Acid-base characteristics of bromophenol blue-citrate buffer systems in the amorphous state. J Pharm Sci, 2004;93:697-712.
17. Luana Perioli L, Ambrogi V, Venezia L, Pagano C, Ricci M, Rossi C. Chitosan and amodified chitosan as agents to improve performances of mucoadhesive vaginal gels. Colloids Surf B: Biointerfaces, 2008;66:141-5.
18. Mi FL, Shyu S-S, Chen SS, Schoung JY. Porous chitosan microparticless for controlling the antigen release of new castle vaccine: Preparation of antigen-adsorbed microparticles and in vitro release. Biomaterials, 1999a; 20:1603-12.
19. Mi F-L, Shyu S-S, Lee S-T, Wong T-B. Kinetic study of chitosantripolyphosphate complex reaction and acid-resistive properties of the chitosan-tripolyphosphate gel beads prepared by in-liquid curing method. J Polym Sci Part B: Polym Phys, 1999b; 37:1551-64.
20. Mi FL, Shyu SS, Wong T, Jang SF, Lee ST, Lu KT. Chitosan polyelectrolyte complexation for the preparation of gel microparticles and controlled release of anticancer drug. I. Effect of pH-dependent ionic cross-linking or interpolymer complex using tripolyphosphate reagent. J Appl Polym Sci, 1999c; 74:1093-107.
21. Mi FL, Sung HW, Shyu SS. Release of indomethacin from a novel chitosan microspheres prepared by naturally occurring crosslinker: Examination of crosslinking and polycation-anionic drug interaction. J Appl Polym Sci, 2001;81:1700-11.
22. Mutalik S, Anju P, Manoja K, Ushaa AN. Enhancement of dissolution rate and bioavailability of aceclofenac: A chitosan-based solvent change approach. Int J Pharm, 2008;350:279-90.
23. Nalva HS, 1997. Spectroscopy and physical properties. Chapter 3. New York: John Wiley & Sons.
24. Paños I, Acosta N, Heras A. New drug delivery systems based on chitosan. Curr Drug Discov Technol, 2008;5(4):333-41.
25. Portero A, Teijeiro-Osorio D, Alonso MJ, Remunan-Lopez C. Development of chitosan sponges for buccal administration of insulin. Carbohydr Polymers, 2007;68:617-25.
26. Remuňán-Lǒpez C, Bodmeier R. Mechanical, water uptake and permeability properties of crosslinked chitosan glutamate and alginate films. J Contr Rel, 1997;44:215-25.
27. Ritger PL, Peppas NA. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J Contr Rel, 1987;5:37-42.
28. Rokhade AP, Agnihotri SA, Patil SA, Mallikarjuna NN, Kulkarni PV, Aminabhavi TM. Semi-interpenetrating polymer network microspheres of gelatin and sodium carboxymethylcellulose for controlled release of ketorolac tromethamine. Carbohydr Polymers, 2006;65:243-52.
29. Rokhade AP, Shelke NB, Patil SA, Aminabhavi TM. Novel interpenetrating polymer network microparticless of chitosan and methylcellulose for controlled release of theophylline. Carbohydr Polymers, 2007;69:678-87.
30. Rossi S, Sandri G, Ferrari F, Bonferoni MC, Caramella C. Buccal delivery of acyclovir from films based on chitosan and polyacrylic acid. Drug Dev Ind Pharm, 2003;8:199-203.
31. Sahoo S, Sasmal A, Nanda R, Phani AR, Nayak PL. Synthesis of chitosan-polycaprolactone blend for control delivery of ofloxacin drug. Carbohydr Polymers, 2010;79:106-13.
32. Satyanarayana S, Kilari EK. Influence of nicorandil on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits. Mol Cell Biochem, 2006;291:101-5.
33. Schernthaner G. Gliclazide modified release: A critical review of pharmacodynamic, metabolic, and vasoprotective effects. Metabolism, 2003;52:29-34.
34. Senel S, Ikinci G, Kas S, Yousefi-Rad A, Sargon MF, Hincal AA. Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery. Int J Pharm, 2000a; 193:197-203.
35. Senel S, Kremer MJ, Kas S, Wertz PW, Hincal AA, Squier CA. Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. Biomaterials, 2000b; 21:2067-71.
36. Sezer AD, Akbuǧa J. Controlled release of piroxicam from chitosan beads. Int J Pharm, 1995;121:113-16.
37. Shu XZ, Zhu KJ. A novel approach to prepare tripolyphosphate/chitosan complex microparticles for controlled release drug delivery. Int J Pharm, 2000;201:51-8.
38. Shu XZ, Zhu KJ. The influence of multivalent phosphate structure on the properties of ionically cross-linked chitosan films for controlled drug release. Eur J Pharm Biopharm, 2002;54:235-43.
39. Shu XZ, Zhu KJ, Song WH. Novel pH-sensitive citrate cross-linked chitosan film for drug controlled release. Int J Pharm, 2001;212:19-28.
40. Sun X-F, Wang S-G, Liu X-W, Gong W-X, Bao N, Ma Y. The effect of pH and ionic strength on fulvic acid uptake by chitosan hydrogel microparticles. Colloids Surf A: Physicochem Eng Aspects, 2008;324:28-34.
41. Tao Y, Lu Y, Sun Y, Gu B, Lu W, Pan J. Development of mucoadhesive microparticles of acyclovir with enhanced bioavailability. Int J Pharm, 2009;378:30-6.
42. Tengamnuay P, Sahamethapat A, Sailasuta A, Mitra AK. Chitosan as nasal absorption enhancers of peptides: Comparison between free amine chitosans and soluble salts. Int J Pharm, 2000;197:53-67.
43. Witschi C, Mrsny RJ. In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery. Pharm Res, 1999;16:382-90.
44. Yassin AB, Alsarra IA, Al-Mohizea AM. Chitosan beads as a new gastroretentive system of verapamil. Sci Pharm, 2006;74:175-88.
45. Zerrouka N, Menninib N, Maestrellib F, Chemtoba C, Mura P. Comparison of the effect of chitosan and polyvinylpyrrolidone on dissolution properties and analgesic effect of naproxen. Eur J Pharm Biopharm, 2004;57:93-9.